SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE was reported 21626 times

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS 12 0.9231
1 ANTI FACTOR V ANTIBODY 12 0.4286
2 CONGENITAL GREAT VESSEL ANOMALY 11 0.2391
3 BLOOD LACTIC ACID 21 0.1628
4 PNEUMOBILIA 19 0.1145
5 BILE DUCT STENT INSERTION 38 0.0995
6 ADENOCARCINOMA PANCREAS 104 0.0809
7 PANCREATIC CARCINOMA METASTATIC 212 0.0745
8 PANCREATICODUODENECTOMY 45 0.0678
9 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 19 0.0615
10 PANCREATECTOMY 27 0.0484
11 ANION GAP ABNORMAL 11 0.0410
12 ANAEMIA VITAMIN B12 DEFICIENCY 20 0.0404
13 TUMOUR INVASION 15 0.0308
14 HYPERLIPASAEMIA 16 0.0305
15 LUNG DIFFUSION TEST DECREASED 12 0.0301
16 DIABETIC METABOLIC DECOMPENSATION 39 0.0281
17 DIABETIC HYPEROSMOLAR COMA 12 0.0278
18 SPLENIC VEIN THROMBOSIS 14 0.0276
19 PANCREATIC NEOPLASM 33 0.0267
20 SPLENECTOMY 29 0.0250
21 DIABETES MELLITUS INADEQUATE CONTROL 423 0.0239
22 PANCREATITIS CHRONIC 56 0.0236
23 MALIGNANT ASCITES 17 0.0222
24 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 26 0.0217
25 RADIOTHERAPY 39 0.0204
26 PANCREATIC CARCINOMA 588 0.0203
27 ADRENAL ADENOMA 12 0.0201
28 DIABETIC COMPLICATION 51 0.0200
29 ADRENAL MASS 16 0.0193
30 PANCREATIC MASS 19 0.0178
31 LACTIC ACIDOSIS 566 0.0175
32 ESSENTIAL HYPERTENSION 29 0.0158
33 METASTASES TO PERITONEUM 40 0.0158
34 PANCREATIC CYST 29 0.0152
35 MEDICATION RESIDUE PRESENT 70 0.0147
36 HYPERLACTACIDAEMIA 39 0.0145
37 ANAEMIA OF CHRONIC DISEASE 13 0.0144
38 EUGLYCAEMIC DIABETIC KETOACIDOSIS 58 0.0140
39 BLOOD GLUCOSE ABNORMAL 256 0.0138
40 BILE DUCT OBSTRUCTION 26 0.0137
41 BALANOPOSTHITIS 11 0.0134
42 DIABETIC NEUROPATHY 66 0.0133
43 AORTIC ARTERIOSCLEROSIS 32 0.0124
44 GLYCOSYLATED HAEMOGLOBIN INCREASED 311 0.0123
45 DIVERTICULUM INTESTINAL 53 0.0121
46 CHOLANGIOCARCINOMA 18 0.0121
47 LIPASE INCREASED 91 0.0119
48 PANCREATITIS 626 0.0118
49 BILE DUCT STENOSIS 14 0.0117
50 BLOOD GLUCOSE FLUCTUATION 123 0.0112
51 GLYCOSYLATED HAEMOGLOBIN DECREASED 18 0.0112
52 METASTASES TO LIVER 192 0.0109
53 OBSTRUCTION GASTRIC 14 0.0109
54 BONE MARROW OEDEMA 11 0.0106
55 AMYLASE INCREASED 38 0.0103
56 RENAL CYST 81 0.0102
57 TONSILLECTOMY 17 0.0102
58 KETOACIDOSIS 76 0.0101
59 URINE KETONE BODY PRESENT 16 0.0101
60 INFUSION SITE WARMTH 12 0.0098
61 HYPOGLYCAEMIC COMA 28 0.0097
62 HYPERLIPIDAEMIA 113 0.0094
63 PANCREATITIS NECROTISING 21 0.0091
64 PULSE ABNORMAL 22 0.0091
65 DIABETIC KETOACIDOSIS 215 0.0089
66 METASTASES TO LYMPH NODES 60 0.0089
67 VENOUS OCCLUSION 16 0.0088
68 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 617 0.0087
69 PROSTATOMEGALY 33 0.0084
70 GASTROSTOMY 13 0.0084
71 PANCREATIC ENZYMES INCREASED 12 0.0082
72 BILIARY DILATATION 12 0.0082
73 BLOOD GLUCOSE INCREASED 1511 0.0080
74 HYPERGLYCAEMIA 287 0.0079
75 INABILITY TO AFFORD MEDICATION 78 0.0078
76 PANCREATITIS ACUTE 173 0.0077
77 DIVERTICULUM 53 0.0075
78 ANGIOPLASTY 11 0.0074
79 HYPOGLYCAEMIA 356 0.0073
80 HYPERKALAEMIA 249 0.0071
81 METABOLIC ENCEPHALOPATHY 21 0.0070
82 OCULOGYRIC CRISIS 15 0.0070
83 BENIGN PROSTATIC HYPERPLASIA 36 0.0070
84 POLYDIPSIA 27 0.0068
85 HEPATIC MASS 13 0.0067
86 SPINAL OSTEOARTHRITIS 59 0.0067
87 NEPHROGENIC ANAEMIA 31 0.0067
88 CHOLECYSTECTOMY 76 0.0066
89 UMBILICAL HERNIA 31 0.0066
90 PEMPHIGOID 50 0.0066
91 ABNORMAL LOSS OF WEIGHT 45 0.0066
92 DYSPNOEA AT REST 19 0.0066
93 CELL DEATH 13 0.0065
94 VITAMIN B12 DEFICIENCY 26 0.0064
95 GASTROINTESTINAL TUBE INSERTION 16 0.0064
96 DIABETIC NEPHROPATHY 14 0.0064
97 MICROCYTIC ANAEMIA 13 0.0062
98 HEPATIC LESION 27 0.0062
99 URINE OUTPUT INCREASED 16 0.0061
100 HAEMORRHAGIC ANAEMIA 26 0.0059
101 TOE AMPUTATION 30 0.0059
102 ATELECTASIS 57 0.0059
103 HEPATIC STEATOSIS 108 0.0058
104 HERNIA REPAIR 15 0.0058
105 JAUNDICE CHOLESTATIC 20 0.0057
106 LARGE INTESTINE POLYP 39 0.0056
107 ACUTE KIDNEY INJURY 838 0.0055
108 STENT PLACEMENT 44 0.0055
109 METASTASES TO LUNG 63 0.0054
110 IMMUNE-MEDIATED MYOSITIS 15 0.0054
111 THYROID NEOPLASM 15 0.0054
112 PULMONARY MASS 81 0.0054
113 BACTERIAL TEST POSITIVE 12 0.0054
114 PRODUCT RESIDUE PRESENT 29 0.0054
115 CEREBRAL HAEMATOMA 18 0.0054
116 APPENDICECTOMY 19 0.0053
117 CHRONIC GASTRITIS 12 0.0053
118 GASTRIC POLYPS 12 0.0053
119 HEPATIC CYST 18 0.0053
120 HYPERCHOLESTEROLAEMIA 51 0.0053
121 BLOOD GLUCOSE DECREASED 251 0.0052
122 GOITRE 21 0.0051
123 INTRA-ABDOMINAL HAEMORRHAGE 12 0.0050
124 DIABETIC RETINOPATHY 17 0.0050
125 LUNG OPACITY 13 0.0049
126 CATARACT OPERATION 29 0.0049
127 VASCULAR GRAFT 14 0.0049
128 PRODUCT SIZE ISSUE 26 0.0048
129 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
130 BLOOD PHOSPHORUS INCREASED 13 0.0048
131 DYSLIPIDAEMIA 24 0.0047
132 TYPE 2 DIABETES MELLITUS 159 0.0047
133 SLEEP APNOEA SYNDROME 89 0.0047
134 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 19 0.0046
135 INJECTION SITE NODULE 51 0.0046
136 RESPIRATORY SYMPTOM 13 0.0046
137 BLOOD CHOLESTEROL ABNORMAL 21 0.0045
138 CORONAVIRUS INFECTION 30 0.0045
139 ABDOMINAL MASS 12 0.0045
140 METABOLIC ACIDOSIS 141 0.0044
141 BLOOD MAGNESIUM DECREASED 38 0.0044
142 URINE ABNORMALITY 20 0.0044
143 EPIGASTRIC DISCOMFORT 17 0.0043
144 CHOLELITHIASIS 141 0.0043
145 SUSPECTED COUNTERFEIT PRODUCT 17 0.0043
146 POOR QUALITY PRODUCT ADMINISTERED 45 0.0043
147 INFARCTION 29 0.0042
148 DUODENITIS 13 0.0042
149 RENAL TUBULAR NECROSIS 41 0.0042
150 BILE DUCT STONE 13 0.0041
151 PERIPHERAL VASCULAR DISORDER 21 0.0041
152 HYPERTENSIVE CRISIS 45 0.0040
153 CAROTID ARTERY STENOSIS 14 0.0040
154 ESCHERICHIA URINARY TRACT INFECTION 17 0.0040
155 NECROTISING FASCIITIS 14 0.0040
156 IMPAIRED GASTRIC EMPTYING 54 0.0040
157 ABDOMINAL HERNIA 18 0.0039
158 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15 0.0039
159 HYSTERECTOMY 34 0.0039
160 DIABETIC FOOT 12 0.0039
161 IRON DEFICIENCY ANAEMIA 36 0.0039
162 PRODUCT COLOUR ISSUE 20 0.0039
163 FULL BLOOD COUNT ABNORMAL 41 0.0039
164 PANCREATIC DISORDER 19 0.0039
165 GOUT 69 0.0038
166 TYPE 1 DIABETES MELLITUS 23 0.0038
167 HEPATOCELLULAR INJURY 54 0.0038
168 BLOOD LACTIC ACID INCREASED 20 0.0038
169 POLYURIA 31 0.0038
170 LIMB OPERATION 18 0.0037
171 CARDIAC PACEMAKER INSERTION 22 0.0037
172 ARTERIAL OCCLUSIVE DISEASE 29 0.0037
173 VARICOSE VEIN 19 0.0037
174 ARTERIOSCLEROSIS 34 0.0036
175 MALNUTRITION 40 0.0036
176 CUTANEOUS VASCULITIS 13 0.0036
177 GASTROINTESTINAL MOTILITY DISORDER 19 0.0035
178 VIITH NERVE PARALYSIS 12 0.0035
179 HIATUS HERNIA 45 0.0035
180 HEPATIC CIRRHOSIS 65 0.0035
181 PRODUCT DISTRIBUTION ISSUE 32 0.0034
182 AORTIC STENOSIS 12 0.0034
183 NO ADVERSE EVENT 623 0.0034
184 GASTRITIS EROSIVE 16 0.0034
185 GASTROOESOPHAGEAL REFLUX DISEASE 274 0.0034
186 DIABETES MELLITUS 259 0.0034
187 CHOLANGITIS 21 0.0034
188 TUBULOINTERSTITIAL NEPHRITIS 63 0.0034
189 EYE MOVEMENT DISORDER 23 0.0034
190 PRODUCT DOSE OMISSION 217 0.0033
191 THYROID CANCER 40 0.0033
192 CORONARY ARTERY BYPASS 19 0.0033
193 INGUINAL HERNIA 20 0.0033
194 CHOLECYSTITIS CHRONIC 22 0.0033
195 HYPOVOLAEMIA 19 0.0032
196 METASTATIC NEOPLASM 14 0.0032
197 PRODUCT SUPPLY ISSUE 23 0.0032
198 GALLBLADDER OPERATION 13 0.0032
199 CHRONIC KIDNEY DISEASE 242 0.0032
200 VITAMIN D DEFICIENCY 31 0.0032
201 BLOOD TRIGLYCERIDES INCREASED 56 0.0032
202 GANGRENE 19 0.0031
203 ANURIA 27 0.0031
204 PERIPHERAL COLDNESS 43 0.0031
205 HYPOMAGNESAEMIA 43 0.0031
206 METASTASIS 22 0.0031
207 DISEASE COMPLICATION 14 0.0031
208 IMMUNE THROMBOCYTOPENIA 14 0.0031
209 CARDIAC FAILURE CHRONIC 13 0.0030
210 VULVOVAGINAL MYCOTIC INFECTION 12 0.0030
211 SHOULDER OPERATION 13 0.0030
212 FUNGAL INFECTION 101 0.0030
213 ACUTE CORONARY SYNDROME 25 0.0030
214 NEPHROLITHIASIS 138 0.0030
215 ERYSIPELAS 15 0.0030
216 IMMOBILE 13 0.0030
217 DUODENAL ULCER 21 0.0030
218 EMPHYSEMA 30 0.0030
219 HAEMORRHOIDS 58 0.0030
220 CATHETERISATION CARDIAC 13 0.0029
221 PRODUCT PHYSICAL ISSUE 59 0.0029
222 CORONARY ARTERY OCCLUSION 40 0.0029
223 CARDIAC OPERATION 25 0.0029
224 CARDIAC MURMUR 25 0.0029
225 PYELONEPHRITIS 25 0.0029
226 SUBDURAL HAEMATOMA 41 0.0029
227 HEPATOMEGALY 28 0.0028
228 POLYP 18 0.0027
229 GALLBLADDER DISORDER 49 0.0027
230 PHARYNGITIS 34 0.0027
231 GASTRITIS 72 0.0027
232 ATRIOVENTRICULAR BLOCK COMPLETE 18 0.0027
233 MALABSORPTION 14 0.0027
234 IRON DEFICIENCY 12 0.0027
235 RENAL FAILURE 354 0.0027
236 DYSURIA 98 0.0027
237 POLLAKIURIA 111 0.0027
238 BLOOD CHOLESTEROL INCREASED 124 0.0027
239 INCORRECT DOSAGE ADMINISTERED 13 0.0027
240 CHOLECYSTITIS ACUTE 15 0.0026
241 OSTEOARTHRITIS 112 0.0026
242 DERMATITIS BULLOUS 19 0.0026
243 MUCOUS STOOLS 13 0.0026
244 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
245 RENAL FAILURE ACUTE 111 0.0026
246 HEPATITIS ACUTE 17 0.0026
247 RENAL FAILURE CHRONIC 20 0.0026
248 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
249 HYPERVENTILATION 15 0.0026
250 RENAL FUNCTION TEST ABNORMAL 12 0.0026
251 WEIGHT FLUCTUATION 27 0.0026
252 WEIGHT DECREASED 718 0.0026
253 NEPHROPATHY 24 0.0026
254 CORONARY ARTERIAL STENT INSERTION 13 0.0026
255 SPLENOMEGALY 30 0.0026
256 NOCTURIA 31 0.0026
257 VAGINAL INFECTION 12 0.0025
258 CORONARY ARTERY DISEASE 77 0.0025
259 INFUSION SITE SWELLING 16 0.0025
260 LEUKOCYTOSIS 46 0.0025
261 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
262 GLOMERULAR FILTRATION RATE DECREASED 31 0.0025
263 FAILURE TO THRIVE 13 0.0025
264 PRODUCT AVAILABILITY ISSUE 57 0.0025
265 ENTERITIS 16 0.0025
266 ABDOMINAL ABSCESS 11 0.0025
267 ACIDOSIS 19 0.0025
268 FLATULENCE 140 0.0025
269 SHOCK HAEMORRHAGIC 20 0.0025
270 FLANK PAIN 23 0.0025
271 ABNORMAL FAECES 20 0.0024
272 CHOLECYSTITIS 29 0.0024
273 RENAL DISORDER 113 0.0024
274 HYDRONEPHROSIS 18 0.0024
275 BLOOD ALBUMIN DECREASED 19 0.0024
276 HAEMATURIA 82 0.0024
277 GLAUCOMA 46 0.0024
278 UROSEPSIS 22 0.0024
279 HYPERCHLORHYDRIA 14 0.0024
280 VULVOVAGINAL PRURITUS 12 0.0024
281 GASTRIC ULCER 45 0.0024
282 HYPERKERATOSIS 13 0.0024
283 HYPOTHYROIDISM 75 0.0023
284 BLOOD TESTOSTERONE DECREASED 16 0.0023
285 ERECTILE DYSFUNCTION 60 0.0023
286 ATRIOVENTRICULAR BLOCK 18 0.0023
287 END STAGE RENAL DISEASE 42 0.0023
288 NODULE 30 0.0023
289 CARPAL TUNNEL SYNDROME 32 0.0023
290 FOOD POISONING 12 0.0022
291 THIRST 40 0.0022
292 EOSINOPHILIA 39 0.0022
293 PRODUCT PRESCRIBING ERROR 53 0.0022
294 GASTROENTERITIS VIRAL 40 0.0022
295 ABDOMINAL TENDERNESS 11 0.0022
296 BLOOD PRESSURE FLUCTUATION 53 0.0022
297 BLOOD CREATININE INCREASED 144 0.0022
298 SMALL INTESTINAL OBSTRUCTION 27 0.0022
299 HEPATITIS 56 0.0022
300 ISCHAEMIC STROKE 39 0.0022
301 HAIR DISORDER 18 0.0022
302 ERUCTATION 42 0.0022
303 HYPERTENSION 459 0.0022
304 DIARRHOEA 1398 0.0022
305 LOWER GASTROINTESTINAL HAEMORRHAGE 16 0.0022
306 TRANSIENT ISCHAEMIC ATTACK 73 0.0022
307 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
308 ADVERSE EVENT 199 0.0022
309 PRODUCT DISPENSING ERROR 47 0.0022
310 BLOOD POTASSIUM INCREASED 35 0.0022
311 HELICOBACTER INFECTION 22 0.0021
312 BLOOD COUNT ABNORMAL 32 0.0021
313 NEUTROPHILIA 12 0.0021
314 PIGMENTATION DISORDER 13 0.0021
315 DRUG DOSE OMISSION 347 0.0021
316 ACCIDENT 25 0.0021
317 WRONG TECHNIQUE IN DRUG USAGE PROCESS 76 0.0021
318 HEPATIC FAILURE 63 0.0021
319 BOWEL MOVEMENT IRREGULARITY 16 0.0021
320 PRODUCT DOSE OMISSION ISSUE 614 0.0021
321 SHOCK 48 0.0021
322 WRONG PRODUCT ADMINISTERED 14 0.0021
323 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373 0.0021
324 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
325 BLOOD PRESSURE ABNORMAL 41 0.0021
326 INTERVERTEBRAL DISC PROTRUSION 45 0.0021
327 BLOOD URINE PRESENT 39 0.0021
328 DEHYDRATION 273 0.0020
329 LYMPHADENOPATHY 72 0.0020
330 DYSPHAGIA 193 0.0020
331 CHOLESTASIS 39 0.0020
332 GAMMA-GLUTAMYLTRANSFERASE INCREASED 45 0.0020
333 MYOCARDIAL INFARCTION 354 0.0020
334 DRUG DISPENSING ERROR 31 0.0020
335 URINARY INCONTINENCE 60 0.0020
336 DYSPEPSIA 199 0.0020
337 UPPER GASTROINTESTINAL HAEMORRHAGE 34 0.0020
338 EATING DISORDER 43 0.0020
339 GASTRIC DISORDER 69 0.0020
340 SKIN LESION 55 0.0020
341 MELAENA 44 0.0020
342 OSTEOMYELITIS 36 0.0020
343 RENAL IMPAIRMENT 167 0.0020
344 ELECTROLYTE IMBALANCE 23 0.0020
345 HYPONATRAEMIA 111 0.0020
346 CATARACT 117 0.0020
347 ACUTE PULMONARY OEDEMA 11 0.0020
348 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
349 CARDIOMEGALY 24 0.0019
350 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
351 SKIN MASS 13 0.0019
352 URINE OUTPUT DECREASED 17 0.0019
353 BLOOD IRON DECREASED 23 0.0019
354 HUNGER 27 0.0019
355 TONGUE DISORDER 14 0.0019
356 FEELING HOT 118 0.0019
357 PRE-EXISTING CONDITION IMPROVED 12 0.0019
358 PRODUCT LABEL ISSUE 13 0.0019
359 BLOOD UREA INCREASED 32 0.0019
360 ASCITES 56 0.0019
361 BLADDER CANCER 112 0.0019
362 PRURITUS GENERALISED 41 0.0019
363 RENAL PAIN 20 0.0019
364 TOXIC SKIN ERUPTION 19 0.0019
365 BLOOD PRESSURE INCREASED 288 0.0019
366 PRODUCT PRESCRIBING ISSUE 41 0.0019
367 CIRCULATORY COLLAPSE 32 0.0019
368 COLON CANCER 28 0.0019
369 DIVERTICULITIS 52 0.0019
370 EYE HAEMORRHAGE 25 0.0019
371 MOVEMENT DISORDER 60 0.0019
372 ABDOMINAL PAIN 434 0.0019
373 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 63 0.0019
374 URINARY TRACT INFECTION 318 0.0019
375 SEPTIC SHOCK 81 0.0019
376 COAGULOPATHY 31 0.0019
377 ABDOMINAL DISCOMFORT 312 0.0019
378 PSYCHOLOGICAL TRAUMA 16 0.0019
379 RASH GENERALISED 48 0.0019
380 ANGINA PECTORIS 53 0.0018
381 DECUBITUS ULCER 15 0.0018
382 ORTHOSTATIC HYPOTENSION 32 0.0018
383 ANGIOEDEMA 81 0.0018
384 CEREBROVASCULAR ACCIDENT 310 0.0018
385 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
386 JAUNDICE 49 0.0018
387 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 95 0.0018
388 OBESITY 29 0.0018
389 LOCALISED INFECTION 44 0.0018
390 ACUTE RESPIRATORY FAILURE 35 0.0018
391 VENTRICULAR TACHYCARDIA 30 0.0018
392 COLD SWEAT 32 0.0018
393 FLUSHING 184 0.0018
394 CONCUSSION 14 0.0018
395 SQUAMOUS CELL CARCINOMA 17 0.0018
396 BLOOD SODIUM DECREASED 34 0.0018
397 CARDIAC FAILURE ACUTE 12 0.0018
398 CHOKING 35 0.0018
399 DRUG ADMINISTRATION ERROR 55 0.0018
400 DECREASED APPETITE 416 0.0018
401 BREAST MASS 12 0.0018
402 INJECTION SITE EXTRAVASATION 22 0.0018
403 ANAL INCONTINENCE 16 0.0018
404 UTERINE LEIOMYOMA 13 0.0018
405 SKIN PLAQUE 15 0.0018
406 STATUS EPILEPTICUS 20 0.0018
407 ILEUS 22 0.0018
408 NEUROPATHY PERIPHERAL 168 0.0018
409 HYPOPHAGIA 45 0.0018
410 MUSCULOSKELETAL CHEST PAIN 27 0.0017
411 ANKLE FRACTURE 27 0.0017
412 ABDOMINAL PAIN UPPER 359 0.0017
413 JOINT EFFUSION 12 0.0017
414 POOR VENOUS ACCESS 18 0.0017
415 OESOPHAGITIS 19 0.0017
416 ENCEPHALITIS 12 0.0017
417 NERVE COMPRESSION 16 0.0017
418 TOOTH FRACTURE 19 0.0017
419 TRANSFUSION 18 0.0017
420 GASTROENTERITIS 25 0.0017
421 AORTIC ANEURYSM 13 0.0017
422 METASTASES TO BONE 28 0.0017
423 RHABDOMYOLYSIS 71 0.0017
424 ANAEMIA 324 0.0017
425 ULCER 27 0.0017
426 ANGINA UNSTABLE 11 0.0017
427 CONSTIPATION 369 0.0017
428 ASTHMA 191 0.0017
429 FOOT FRACTURE 32 0.0017
430 HAIR COLOUR CHANGES 21 0.0017
431 THYROID DISORDER 26 0.0017
432 BACTERAEMIA 20 0.0017
433 RETINAL HAEMORRHAGE 12 0.0017
434 LUNG INFECTION 26 0.0017
435 HAEMORRHAGIC STROKE 13 0.0017
436 VOMITING 781 0.0017
437 PRODUCT USE ISSUE 312 0.0017
438 BACK INJURY 18 0.0017
439 EXPIRED PRODUCT ADMINISTERED 55 0.0017
440 PRESCRIBED OVERDOSE 32 0.0017
441 CELLULITIS 83 0.0016
442 HYPERHIDROSIS 212 0.0016
443 BLOOD TEST ABNORMAL 23 0.0016
444 ROTATOR CUFF SYNDROME 21 0.0016
445 KNEE OPERATION 16 0.0016
446 POOR QUALITY SLEEP 35 0.0016
447 PRODUCT ODOUR ABNORMAL 17 0.0016
448 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
449 PULMONARY FIBROSIS 31 0.0016
450 HEPATIC ENCEPHALOPATHY 15 0.0016
451 HYPOKALAEMIA 74 0.0016
452 ACCIDENTAL UNDERDOSE 23 0.0016
453 HEART RATE IRREGULAR 36 0.0016
454 DRY MOUTH 129 0.0016
455 BODY HEIGHT DECREASED 17 0.0016
456 PRODUCT USE COMPLAINT 25 0.0016
457 MUSCULOSKELETAL PAIN 83 0.0016
458 ABDOMINAL DISTENSION 165 0.0016
459 ESCHERICHIA INFECTION 13 0.0016
460 MUSCLE ATROPHY 20 0.0016
461 APHONIA 22 0.0016
462 FEELING JITTERY 30 0.0016
463 TRANSAMINASES INCREASED 35 0.0016
464 PRODUCTIVE COUGH 75 0.0016
465 WRONG DRUG ADMINISTERED 14 0.0016
466 CYSTITIS 50 0.0016
467 INSURANCE ISSUE 24 0.0016
468 SCIATICA 25 0.0016
469 CARDIAC ARREST 129 0.0016
470 CARDIOMYOPATHY 23 0.0016
471 PRESCRIBED UNDERDOSE 31 0.0016
472 PRODUCT TASTE ABNORMAL 21 0.0015
473 LOCAL SWELLING 27 0.0015
474 BRADYCARDIA 82 0.0015
475 PLEURAL EFFUSION 94 0.0015
476 PARALYSIS 22 0.0015
477 GENERALISED OEDEMA 19 0.0015
478 COMA 73 0.0015
479 MULTIPLE ALLERGIES 12 0.0015
480 URINARY RETENTION 51 0.0015
481 ACUTE MYOCARDIAL INFARCTION 45 0.0015
482 VITREOUS FLOATERS 15 0.0015
483 PROSTATIC SPECIFIC ANTIGEN INCREASED 21 0.0015
484 ASTHENIA 572 0.0015
485 GASTROINTESTINAL DISORDER 136 0.0015
486 LIMB INJURY 41 0.0015
487 EYE INFECTION 17 0.0015
488 ATRIAL FLUTTER 12 0.0015
489 MIDDLE INSOMNIA 28 0.0015
490 SKIN DISORDER 50 0.0015
491 BLOOD POTASSIUM DECREASED 45 0.0015
492 HAIR TEXTURE ABNORMAL 20 0.0015
493 VERTIGO 91 0.0015
494 SENSORY LOSS 12 0.0015
495 INJECTION SITE MASS 55 0.0015
496 HEPATIC ENZYME INCREASED 101 0.0015
497 BALANCE DISORDER 128 0.0015
498 PRESYNCOPE 36 0.0015
499 GASTRIC HAEMORRHAGE 17 0.0015
500 FAECES DISCOLOURED 32 0.0015
501 INFUSION SITE PAIN 19 0.0015
502 LUNG INFILTRATION 13 0.0015
503 PERICARDIAL EFFUSION 34 0.0015
504 LUNG DISORDER 72 0.0015
505 WOUND INFECTION 16 0.0015
506 TENDON RUPTURE 18 0.0015
507 CHEST PAIN 270 0.0015
508 DRUG PRESCRIBING ERROR 28 0.0015
509 ARRHYTHMIA 69 0.0015
510 LIMB DISCOMFORT 45 0.0015
511 CARDIAC DISORDER 136 0.0015
512 OEDEMA PERIPHERAL 177 0.0015
513 GASTROINTESTINAL INFECTION 13 0.0014
514 SURGERY 85 0.0014
515 FREQUENT BOWEL MOVEMENTS 39 0.0014
516 NERVE INJURY 16 0.0014
517 TOOTHACHE 26 0.0014
518 GASTROINTESTINAL CARCINOMA 13 0.0014
519 SPEECH DISORDER 75 0.0014
520 DEMENTIA 40 0.0014
521 EYE DISORDER 47 0.0014
522 NIGHT SWEATS 46 0.0014
523 THERAPY CHANGE 14 0.0014
524 LYMPHOMA 22 0.0014
525 BODY TEMPERATURE DECREASED 14 0.0014
526 LIVER DISORDER 63 0.0014
527 PROTEINURIA 27 0.0014
528 FALL 472 0.0014
529 BRAIN NEOPLASM 13 0.0014
530 RENAL INJURY 42 0.0014
531 MITRAL VALVE INCOMPETENCE 16 0.0014
532 HAEMATOCRIT DECREASED 28 0.0014
533 ARTHRITIS 111 0.0014
534 DRUG ERUPTION 25 0.0014
535 CARDIAC FAILURE CONGESTIVE 113 0.0014
536 MYOCARDIAL ISCHAEMIA 16 0.0014
537 NAUSEA 1111 0.0014
538 MICTURITION URGENCY 16 0.0014
539 PAIN IN EXTREMITY 412 0.0014
540 PANCYTOPENIA 78 0.0014
541 CARDIOGENIC SHOCK 20 0.0014
542 SEPSIS 155 0.0014
543 OXYGEN SATURATION DECREASED 78 0.0014
544 ATRIAL FIBRILLATION 135 0.0014
545 DIPLOPIA 36 0.0014
546 OSTEOPENIA 21 0.0014
547 HYPOTHERMIA 14 0.0014
548 BACK PAIN 321 0.0014
549 PLATELET COUNT INCREASED 18 0.0014
550 MADAROSIS 16 0.0014
551 HAEMATOCHEZIA 76 0.0014
552 HIP ARTHROPLASTY 21 0.0014
553 INTENTIONAL PRODUCT MISUSE 120 0.0014
554 ASPIRATION 15 0.0014
555 BEDRIDDEN 18 0.0014
556 BLOOD CALCIUM INCREASED 12 0.0014
557 NEUTROPHIL COUNT INCREASED 14 0.0014
558 GASTROINTESTINAL PAIN 15 0.0014
559 PULMONARY OEDEMA 61 0.0014
560 HYPERSOMNIA 39 0.0014
561 INCORRECT DOSE ADMINISTERED 310 0.0014
562 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
563 HEMIPARESIS 23 0.0014
564 PURPURA 12 0.0014
565 RED BLOOD CELL SEDIMENTATION RATE INCREASED 15 0.0014
566 PERIPHERAL SWELLING 208 0.0013
567 RECTAL HAEMORRHAGE 58 0.0013
568 DRUG INTERACTION 214 0.0013
569 RASH MACULO-PAPULAR 30 0.0013
570 GAIT INABILITY 45 0.0013
571 HERNIA 26 0.0013
572 LIVER FUNCTION TEST ABNORMAL 39 0.0013
573 DIZZINESS POSTURAL 13 0.0013
574 HAEMOLYTIC ANAEMIA 12 0.0013
575 MYOSITIS 12 0.0013
576 HYPOAESTHESIA 200 0.0013
577 BLOOD CALCIUM DECREASED 15 0.0013
578 HEART RATE INCREASED 132 0.0013
579 SINUS CONGESTION 18 0.0013
580 FEEDING DISORDER 27 0.0013
581 MYALGIA 226 0.0013
582 KIDNEY INFECTION 26 0.0013
583 PNEUMONITIS 36 0.0013
584 HYPOCALCAEMIA 25 0.0013
585 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
586 RESTLESS LEGS SYNDROME 24 0.0013
587 METASTASES TO CENTRAL NERVOUS SYSTEM 17 0.0013
588 FLUID RETENTION 67 0.0013
589 SOMNOLENCE 265 0.0013
590 VISUAL IMPAIRMENT 163 0.0013
591 LIGAMENT SPRAIN 13 0.0013
592 RETCHING 28 0.0013
593 JOINT INJURY 28 0.0013
594 HAEMOGLOBIN DECREASED 134 0.0013
595 MUSCULAR WEAKNESS 148 0.0013
596 BLINDNESS 53 0.0013
597 DEAFNESS 34 0.0013
598 SPINAL OPERATION 16 0.0013
599 HEAD INJURY 41 0.0013
600 PNEUMOCYSTIS JIROVECII PNEUMONIA 13 0.0013
601 NASAL CONGESTION 76 0.0013
602 BACK DISORDER 21 0.0013
603 CARDIAC FAILURE 103 0.0013
604 AGEUSIA 32 0.0013
605 VISION BLURRED 176 0.0013
606 DIZZINESS 639 0.0013
607 PRODUCT QUALITY ISSUE 174 0.0013
608 DEVICE OCCLUSION 18 0.0013
609 MUSCULOSKELETAL DISCOMFORT 22 0.0013
610 BLINDNESS UNILATERAL 18 0.0013
611 AMNESIA 83 0.0013
612 SPUTUM DISCOLOURED 12 0.0013
613 COUGH 354 0.0013
614 EYE INFLAMMATION 12 0.0013
615 LOSS OF CONSCIOUSNESS 161 0.0013
616 BRONCHITIS 93 0.0013
617 ABASIA 31 0.0013
618 ABSCESS 20 0.0013
619 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
620 BLOOD CREATINE PHOSPHOKINASE INCREASED 36 0.0012
621 LOWER LIMB FRACTURE 24 0.0012
622 GINGIVAL BLEEDING 17 0.0012
623 RESPIRATORY DISORDER 37 0.0012
624 NECK PAIN 69 0.0012
625 DEVICE RELATED INFECTION 19 0.0012
626 BLOOD PRESSURE DECREASED 82 0.0012
627 DYSSTASIA 36 0.0012
628 SCRATCH 13 0.0012
629 RESPIRATORY DISTRESS 34 0.0012
630 RESPIRATORY TRACT INFECTION 32 0.0012
631 PNEUMONIA 396 0.0012
632 DYSPNOEA EXERTIONAL 46 0.0012
633 FEELING COLD 34 0.0012
634 OROPHARYNGEAL PAIN 113 0.0012
635 PRURITUS 468 0.0012
636 GAIT DISTURBANCE 233 0.0012
637 CYST 15 0.0012
638 GASTROINTESTINAL HAEMORRHAGE 101 0.0012
639 BLADDER DISORDER 12 0.0012
640 MEMORY IMPAIRMENT 166 0.0012
641 NERVOUSNESS 63 0.0012
642 PALPITATIONS 141 0.0012
643 PNEUMONIA ASPIRATION 30 0.0012
644 SKIN ULCER 31 0.0012
645 THROMBOCYTOPENIA 134 0.0012
646 HYPOXIA 42 0.0012
647 QUALITY OF LIFE DECREASED 16 0.0012
648 MALAISE 521 0.0012
649 HYPOACUSIS 51 0.0012
650 INFLUENZA 132 0.0012
651 HAEMATEMESIS 30 0.0012
652 TACHYCARDIA 105 0.0012
653 HIP FRACTURE 38 0.0012
654 HYPOTENSION 237 0.0012
655 DRY THROAT 12 0.0012
656 WOUND 33 0.0012
657 TACHYPNOEA 16 0.0012
658 ACCIDENTAL OVERDOSE 43 0.0012
659 DENTAL CARIES 13 0.0012
660 CONTUSION 113 0.0012
661 LIP SWELLING 39 0.0012
662 HYPOKINESIA 17 0.0012
663 BURNING SENSATION 82 0.0012
664 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
665 GENERAL PHYSICAL HEALTH DETERIORATION 135 0.0012
666 RIB FRACTURE 24 0.0012
667 WHEEZING 69 0.0012
668 RHINORRHOEA 75 0.0012
669 FATIGUE 902 0.0012
670 PARAESTHESIA 182 0.0012
671 ARTHROPATHY 64 0.0012
672 PETECHIAE 12 0.0011
673 INTENTIONAL PRODUCT USE ISSUE 100 0.0011
674 ENCEPHALOPATHY 28 0.0011
675 MUSCLE SPASMS 209 0.0011
676 INJECTION SITE PRURITUS 76 0.0011
677 SINUSITIS 116 0.0011
678 INSOMNIA 300 0.0011
679 RASH PRURITIC 61 0.0011
680 ECONOMIC PROBLEM 17 0.0011
681 IRRITABLE BOWEL SYNDROME 24 0.0011
682 EYELID OEDEMA 13 0.0011
683 LABORATORY TEST ABNORMAL 33 0.0011
684 BREAST CANCER METASTATIC 12 0.0011
685 CEREBRAL HAEMORRHAGE 40 0.0011
686 INTERSTITIAL LUNG DISEASE 54 0.0011
687 MENTAL IMPAIRMENT 27 0.0011
688 CONFUSIONAL STATE 180 0.0011
689 DERMATITIS ALLERGIC 14 0.0011
690 UNDERDOSE 81 0.0011
691 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
692 DEEP VEIN THROMBOSIS 72 0.0011
693 WEIGHT INCREASED 248 0.0011
694 MYELODYSPLASTIC SYNDROME 16 0.0011
695 PALLOR 30 0.0011
696 ARTHRALGIA 458 0.0011
697 DYSPNOEA 623 0.0011
698 RED BLOOD CELL COUNT DECREASED 31 0.0011
699 FEELING ABNORMAL 259 0.0011
700 INJECTION SITE INDURATION 14 0.0011
701 PRODUCT SUBSTITUTION ISSUE 62 0.0011
702 PERICARDITIS 18 0.0011
703 ADRENAL INSUFFICIENCY 13 0.0011
704 CHROMATURIA 24 0.0011
705 SINUS DISORDER 21 0.0011
706 TREATMENT NONCOMPLIANCE 58 0.0011
707 APHASIA 32 0.0011
708 PULMONARY HYPERTENSION 22 0.0011
709 LOWER RESPIRATORY TRACT INFECTION 48 0.0011
710 HYPERCALCAEMIA 13 0.0011
711 OEDEMA 57 0.0010
712 INTERNAL HAEMORRHAGE 12 0.0010
713 SYNCOPE 105 0.0010
714 SLEEP DISORDER 74 0.0010
715 THERAPEUTIC RESPONSE UNEXPECTED 47 0.0010
716 MULTI-ORGAN FAILURE 18 0.0010
717 PARAESTHESIA ORAL 15 0.0010
718 DEPRESSION 236 0.0010
719 ANOSMIA 15 0.0010
720 TASTE DISORDER 21 0.0010
721 INJURY ASSOCIATED WITH DEVICE 21 0.0010
722 VASCULITIS 12 0.0010
723 IMPAIRED WORK ABILITY 22 0.0010
724 INJECTION SITE HAEMORRHAGE 82 0.0010
725 VISUAL ACUITY REDUCED 34 0.0010
726 HOT FLUSH 77 0.0010
727 LIVER INJURY 25 0.0010
728 BACTERIAL INFECTION 19 0.0010
729 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
730 DYSPHONIA 59 0.0010
731 LETHARGY 58 0.0010
732 ORAL DISCOMFORT 14 0.0010
733 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
734 CARDIO-RESPIRATORY ARREST 42 0.0010
735 RASH ERYTHEMATOUS 48 0.0010
736 UPPER LIMB FRACTURE 20 0.0010
737 URTICARIA 168 0.0010
738 TINNITUS 46 0.0010
739 RESPIRATORY FAILURE 73 0.0010
740 STAPHYLOCOCCAL INFECTION 33 0.0010
741 DISCOMFORT 61 0.0010
742 MUSCULOSKELETAL DISORDER 19 0.0010
743 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 71 0.0010
744 TOOTH DISORDER 22 0.0010
745 INCORRECT PRODUCT STORAGE 13 0.0010
746 SEASONAL ALLERGY 14 0.0010
747 ORAL CANDIDIASIS 13 0.0010
748 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
749 CARDIOVASCULAR DISORDER 25 0.0010
750 ORAL PAIN 22 0.0010
751 SNEEZING 22 0.0010
752 CYTOPENIA 12 0.0010
753 SKIN DISCOLOURATION 45 0.0010
754 LIVER FUNCTION TEST INCREASED 21 0.0010
755 EPISTAXIS 73 0.0010
756 SKIN CANCER 21 0.0010
757 PHARYNGEAL OEDEMA 15 0.0010
758 ACTIVITIES OF DAILY LIVING IMPAIRED 19 0.0010
759 UVEITIS 13 0.0010
760 BONE PAIN 56 0.0010
761 DYSGEUSIA 71 0.0010
762 POISONING 12 0.0010
763 NASOPHARYNGITIS 176 0.0010
764 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
765 KNEE ARTHROPLASTY 20 0.0009
766 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 192 0.0009
767 CANDIDA INFECTION 16 0.0009
768 FIBROMYALGIA 23 0.0009
769 IMPAIRED HEALING 31 0.0009
770 FULL BLOOD COUNT DECREASED 19 0.0009
771 EMOTIONAL DISORDER 29 0.0009
772 PLATELET COUNT DECREASED 100 0.0009
773 RASH PAPULAR 21 0.0009
774 THROAT IRRITATION 42 0.0009
775 HEADACHE 586 0.0009
776 NEOPLASM MALIGNANT 62 0.0009
777 HAEMATOMA 24 0.0009
778 LUNG NEOPLASM MALIGNANT 38 0.0009
779 ANXIETY 263 0.0009
780 OSTEOPOROSIS 38 0.0009
781 STOMATITIS 56 0.0009
782 TREMOR 153 0.0009
783 SWELLING FACE 60 0.0009
784 DIALYSIS 13 0.0009
785 SINUS TACHYCARDIA 13 0.0009
786 EYE SWELLING 34 0.0009
787 HEART RATE DECREASED 32 0.0009
788 ABDOMINAL PAIN LOWER 23 0.0009
789 THROMBOSIS 73 0.0009
790 LYMPHOCYTE COUNT DECREASED 16 0.0009
791 PULMONARY EMBOLISM 86 0.0009
792 EYE PAIN 51 0.0009
793 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
794 HALLUCINATION 68 0.0009
795 EJECTION FRACTION DECREASED 14 0.0009
796 RASH 392 0.0009
797 HYPERTHYROIDISM 13 0.0009
798 COLITIS 34 0.0009
799 DELIRIUM 31 0.0009
800 EYE PRURITUS 30 0.0009
801 FEAR 24 0.0009
802 BLISTER 50 0.0009
803 OVERDOSE 192 0.0009
804 PSORIATIC ARTHROPATHY 36 0.0009
805 INFLUENZA LIKE ILLNESS 73 0.0009
806 POST PROCEDURAL COMPLICATION 17 0.0009
807 DISORIENTATION 35 0.0009
808 DRUG EFFECT INCOMPLETE 32 0.0009
809 HEPATIC CANCER 21 0.0009
810 ILL-DEFINED DISORDER 53 0.0009
811 SENSORY DISTURBANCE 14 0.0009
812 INFLAMMATION 45 0.0009
813 ALANINE AMINOTRANSFERASE INCREASED 53 0.0009
814 AGRANULOCYTOSIS 16 0.0009
815 ROAD TRAFFIC ACCIDENT 36 0.0009
816 HAEMOPTYSIS 24 0.0009
817 ECZEMA 45 0.0009
818 THERAPY CESSATION 44 0.0009
819 SWELLING 80 0.0009
820 C-REACTIVE PROTEIN INCREASED 31 0.0009
821 CYTOKINE RELEASE SYNDROME 17 0.0008
822 DRUG LEVEL INCREASED 14 0.0008
823 INTENTIONAL DOSE OMISSION 24 0.0008
824 PAIN 517 0.0008
825 MOBILITY DECREASED 60 0.0008
826 ABNORMAL DREAMS 23 0.0008
827 MENINGIOMA 13 0.0008
828 SWOLLEN TONGUE 26 0.0008
829 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
830 INJECTION SITE HAEMATOMA 12 0.0008
831 INTESTINAL OBSTRUCTION 31 0.0008
832 DRY EYE 41 0.0008
833 JOINT SWELLING 99 0.0008
834 ALOPECIA 160 0.0008
835 THROAT TIGHTNESS 22 0.0008
836 ERYTHEMA 167 0.0008
837 PYREXIA 280 0.0008
838 FEMUR FRACTURE 25 0.0008
839 MOUTH ULCERATION 17 0.0008
840 RASH MACULAR 28 0.0008
841 CHEST DISCOMFORT 82 0.0008
842 JOINT STIFFNESS 21 0.0008
843 PHOTOPHOBIA 15 0.0008
844 DRUG INTOLERANCE 77 0.0008
845 DEPRESSED MOOD 42 0.0008
846 CONDITION AGGRAVATED 239 0.0008
847 INCREASED APPETITE 15 0.0008
848 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
849 INJECTION SITE PAIN 240 0.0008
850 VIRAL INFECTION 26 0.0008
851 CHILLS 91 0.0008
852 MUSCULOSKELETAL STIFFNESS 68 0.0008
853 DYSARTHRIA 29 0.0008
854 HYPERSENSITIVITY 143 0.0008
855 FEBRILE NEUTROPENIA 51 0.0008
856 DRUG INEFFECTIVE 1008 0.0008
857 COLITIS ULCERATIVE 34 0.0008
858 SCAR 13 0.0008
859 COVID-19 133 0.0008
860 PSORIASIS 99 0.0008
861 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
862 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
863 PNEUMOTHORAX 12 0.0008
864 APATHY 11 0.0008
865 SPINAL FRACTURE 15 0.0007
866 SEIZURE 86 0.0007
867 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
868 BLOOD BILIRUBIN INCREASED 20 0.0007
869 OCULAR HYPERAEMIA 35 0.0007
870 CEREBRAL INFARCTION 18 0.0007
871 MOOD ALTERED 20 0.0007
872 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
873 INJECTION SITE BRUISING 58 0.0007
874 DISTURBANCE IN ATTENTION 39 0.0007
875 NIGHTMARE 25 0.0007
876 MENTAL STATUS CHANGES 20 0.0007
877 STEVENS-JOHNSON SYNDROME 16 0.0007
878 AGGRESSION 36 0.0007
879 IRRITABILITY 43 0.0007
880 BONE DISORDER 13 0.0007
881 MENTAL DISORDER 31 0.0007
882 INFECTION 103 0.0007
883 TARDIVE DYSKINESIA 20 0.0007
884 PAIN IN JAW 20 0.0007
885 NERVOUS SYSTEM DISORDER 22 0.0007
886 DEATH 606 0.0007
887 PLASMA CELL MYELOMA 27 0.0007
888 FRACTURE 13 0.0007
889 OFF LABEL USE 601 0.0007
890 PROCEDURAL PAIN 19 0.0007
891 EAR INFECTION 18 0.0007
892 EAR PAIN 13 0.0007
893 PAIN OF SKIN 18 0.0007
894 HERPES ZOSTER 38 0.0007
895 HAEMORRHAGE 69 0.0007
896 BREAST CANCER 60 0.0006
897 NEOPLASM PROGRESSION 22 0.0006
898 INJECTION SITE WARMTH 13 0.0006
899 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
900 TOOTH LOSS 13 0.0006
901 DEVICE LEAKAGE 27 0.0006
902 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
903 INJECTION SITE ERYTHEMA 77 0.0006
904 DYSKINESIA 25 0.0006
905 SKIN FISSURES 12 0.0006
906 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
907 MUCOSAL INFLAMMATION 16 0.0006
908 WHITE BLOOD CELL COUNT DECREASED 66 0.0006
909 SKIN BURNING SENSATION 43 0.0006
910 LACRIMATION INCREASED 18 0.0006
911 MEDICATION ERROR 33 0.0006
912 SKIN EXFOLIATION 50 0.0006
913 EPILEPSY 18 0.0006
914 AGITATION 43 0.0006
915 ANAPHYLACTIC SHOCK 15 0.0006
916 HOSPITALISATION 89 0.0006
917 THERAPY NON-RESPONDER 26 0.0006
918 EMOTIONAL DISTRESS 70 0.0006
919 CRYING 21 0.0006
920 DRUG EFFECT DECREASED 31 0.0006
921 RESTLESSNESS 21 0.0006
922 THERAPY INTERRUPTED 41 0.0006
923 DRUG-INDUCED LIVER INJURY 18 0.0006
924 THERAPEUTIC RESPONSE SHORTENED 19 0.0006
925 DERMATITIS 12 0.0006
926 RHEUMATOID ARTHRITIS 65 0.0006
927 ANHEDONIA 15 0.0006
928 HALLUCINATION, VISUAL 12 0.0006
929 EXTRA DOSE ADMINISTERED 23 0.0006
930 SUICIDE ATTEMPT 34 0.0006
931 NEUTROPENIA 75 0.0006
932 INTENTIONAL OVERDOSE 35 0.0005
933 ADVERSE DRUG REACTION 49 0.0005
934 LEUKOPENIA 27 0.0005
935 MALIGNANT NEOPLASM PROGRESSION 55 0.0005
936 NEURALGIA 13 0.0005
937 INJECTION SITE URTICARIA 13 0.0005
938 INJURY 37 0.0005
939 ILLNESS 54 0.0005
940 DEVICE ISSUE 47 0.0005
941 INJECTION SITE SWELLING 40 0.0005
942 DRY SKIN 69 0.0005
943 GASTRIC CANCER 13 0.0005
944 BONE DENSITY DECREASED 16 0.0005
945 TOXICITY TO VARIOUS AGENTS 85 0.0005
946 EYE IRRITATION 29 0.0005
947 UNEVALUABLE EVENT 38 0.0005
948 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
949 PANIC ATTACK 18 0.0005
950 MIGRAINE 47 0.0005
951 PRODUCT USE IN UNAPPROVED INDICATION 121 0.0005
952 NEEDLE ISSUE 14 0.0005
953 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
954 ANGER 16 0.0005
955 PROSTATE CANCER 38 0.0005
956 MOOD SWINGS 15 0.0005
957 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
958 INFUSION RELATED REACTION 30 0.0005
959 COGNITIVE DISORDER 21 0.0004
960 THERAPEUTIC RESPONSE DECREASED 27 0.0004
961 DEVICE MALFUNCTION 31 0.0004
962 RESPIRATORY ARREST 12 0.0004
963 DISEASE PROGRESSION 51 0.0004
964 WITHDRAWAL SYNDROME 18 0.0004
965 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
966 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
967 ABORTION SPONTANEOUS 17 0.0004
968 VAGINAL HAEMORRHAGE 18 0.0004
969 ABNORMAL BEHAVIOUR 16 0.0004
970 DERMATITIS ATOPIC 21 0.0004
971 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
972 MULTIPLE SCLEROSIS RELAPSE 27 0.0004
973 INJECTION SITE RASH 12 0.0004
974 INJECTION SITE REACTION 26 0.0004
975 CONVULSION 21 0.0004
976 RENAL CANCER 17 0.0004
977 PRODUCT STORAGE ERROR 31 0.0004
978 NEUTROPHIL COUNT DECREASED 14 0.0003
979 ANAPHYLACTIC REACTION 18 0.0003
980 SUICIDAL IDEATION 29 0.0003
981 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
982 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
983 SKIN IRRITATION 13 0.0003
984 TREATMENT FAILURE 23 0.0003
985 ACNE 20 0.0003
986 DISEASE RECURRENCE 12 0.0003
987 MULTIPLE SCLEROSIS 12 0.0003
988 EXPOSURE DURING PREGNANCY 13 0.0002
989 COMPLETED SUICIDE 14 0.0002
990 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
991 DRUG DEPENDENCE 19 0.0001